The Study
Genetic association between FADS and ELOVL polymorphisms and the circulating levels of EPA/DHA in humans: a scoping review
This study is like a big summary of many smaller studies that looked at people's genes and their omega-3 levels in the blood. It can tell us that certain gene changes are often seen in people with lower omega-3 levels, but it can't prove the gene change causes the low levels. It's like noticing that most people who wear red shirts also like apples — they're linked, but we don't know if the shirt causes the apple liking.
Analysis score
Maximum 100 for a systematic review.
Where the score came from
Some people have gene differences that make it harder for their bodies to make healthy fats like those in fish oil, even if they eat the right foods.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 520 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This means some people may need to eat more omega-3s from food or supplements because their genes limit natural production.
- 2People with a T version of the rs174537 gene have less EPA and DHA in their blood.
- 347 gene changes in FADS were studied.
- 4Blood levels of EPA and DHA are more clearly linked to genes when measured in plasma or serum.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Genes & Nutrition
Year
2024
Authors
Insaf Loukil, D. Mutch, Mélanie Plourde
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.